ICAHN CARL C
Managed by Carl Icahn · Portfolio as of Q4 2022
Top Holdings16 positions
ICAHN ENTERPRISES LP | 300M | $15.2B | 69.8% | $16.20 | +37.93% | 17 qtrssince 2018-Q4 | Increased 67 |
CVR ENERGY INC | 71.2M | $2.2B | 10.3% | $19.52 | +31.39% | 17 qtrssince 2018-Q4 | Unchanged 0 |
FIRSTENERGY CORP | 19M | $795.5M | 3.7% | $28.13 | +30.25% | 8 qtrssince 2021-Q1 | Unchanged 0 |
| 16.4M | $676.8M | 3.1% | — | — | — | Increased 62 | |
XEROX HOLDINGS CORP | 34.2M | $500M | 2.3% | $15.72 | -23.73% | 4 qtrssince 2022-Q1 | Unchanged 0 |
HERC HLDGS INC | 3.7M | $486.3M | 2.2% | $23.61 | +426.22% | 17 qtrssince 2018-Q4 | Decreased 0 |
NEWELL BRANDS INC | 33.1M | $432.6M | 2.0% | $13.04 | -12.05% | 17 qtrssince 2018-Q4 | Unchanged 0 |
SOUTHWEST GAS HLDGS INC | 6.6M | $409.1M | 1.9% | $65.95 | -15.85% | 6 qtrssince 2021-Q3 | Unchanged 0 |
BAUSCH HEALTH COS INC | 34.7M | $218M | 1.0% | $29.39 | -78.63% | 9 qtrssince 2020-Q4 | Unchanged 0 |
DANA INC | 14.3M | $216.2M | 1.0% | $20.31 | -31.76% | 9 qtrssince 2020-Q4 | Unchanged 0 |
CONDUENT INC | 38.1M | $154.5M | 0.7% | $9.55 | -57.61% | 17 qtrssince 2018-Q4 | Unchanged 0 |
CHENIERE ENERGY INC | 1M | $150M | 0.7% | $55.31 | +161.26% | 17 qtrssince 2018-Q4 | Decreased 0 |
CROWN HLDGS INC | 1M | $85.5M | 0.4% | $77.38 | +2.69% | 2 qtrssince 2022-Q3 | Increased 38 |
SANDRIDGE ENERGY INC | 4.8M | $82.1M | 0.4% | $5.53 | +124.41% | 17 qtrssince 2018-Q4 | Unchanged 0 |
INTERNATIONAL FLAVORS&FRAGRA | 644,510 | $67.6M | 0.3% | $116.34 | -18.32% | 4 qtrssince 2022-Q1 | Unchanged 0 |
BAUSCH PLUS LOMB CORP | 3.5M | $54.3M | 0.2% | $15.28 | +1.51% | 3 qtrssince 2022-Q2 | Unchanged 0 |
ICAHN CARL C manages $21.8B across 16 positions as of Q4 2022. Top holdings: IEP (69.8%), CVI (10.3%), FE (3.7%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.
Exited 1, increased 3, trimmed 2. Top move: IEP (INCREASED, conviction 67). Portfolio: $21.8B across 16 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR